AFIB News and Press, Acutus Medical Inc. From 11/08/23

2023-11-08 17:29:10 ET Acutus Medical press release ( NASDAQ: AFIB ): Q3 Non-GAAP EPS of -$0.52 beats by $0.04 . Revenue of $5.2M (+44.4% Y/Y) beats by $0.36M . Third quarter revenue of $5.2 million grew 44% year-over-year, led by strong growth in distribution ...

CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the third quarter of 2023. Recent Highlights: Third quarter revenue of $5.2 million grew 44% year-over-year, l...

CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and corporate restructuring. Scott Huennekens, Chairman of Acutus, commented, “Following an exte...

CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its third quarter 2023 financial resu...

2023-08-07 22:02:07 ET Acutus Medical, Inc. (AFIB) Q2 2023 Earnings Conference Call August 07, 2023, 04:30 AM ET Company Participants Caroline Corner - IR David Roman - CEO Takeo Mukai - CFO Conference Call Participants Marie Thibault - BTIG John ...

2023-08-07 16:45:20 ET Acutus Medical press release ( NASDAQ: AFIB ): Q2 Non-GAAP EPS of -$0.60 beats by $0.02 . Revenue of $5.3M (+29.3% Y/Y) beats by $0.8M . Cash, cash equivalents, marketable securities and restricted cash were $61.5 million as of June 30,...

CARLSBAD, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the second quart...

CARLSBAD, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the 43 rd Ann...

CARLSBAD, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its second quarter 2023 financial res...

CARLSBAD, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, is pleased to announce its participation in the upcoming Heart Rhythm Socie...